Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Elementum announces two new hires to strengthen its legal, compliance and operational structure

Tuesday, August 21, 2012

From Komfie Manalo, Opalesque Asia – An independent alternative investment manager that specializes in collateralized natural event reinsurance investments announces two new hires to strengthen its legal, compliance and operational infrastructure.

Elementum Advisors' Founding Principal Tony Rettino said that Bobbi Anderson would join the firm as Principal and General Counsel effectively on September 10, 2012, and will transition into the additional role of Chief Compliance Officer on January 1, 2013. Anderson is currently a Partner in the insurance group at Sidley Austin LLP in Chicago where she has been instrumental in shaping the direction of the Insurance Linked Securities asset class through the development of new risk transfer structures and her work with (re)insurance companies on catastrophe bond, collateralized reinsurance and M&A transactions.

Rettino commented on the hiring of Anderson, "We are extremely pleased to welcome Bobbi to our management team. Bobbi is one of the premier attorneys in our asset class and will be an invaluable resource to Elementum and our investors."

Also set to join Elementum is Timothy Williams who will take the helm as director of Investment Operations starting August 31. Williams joins from Legal & General Investment Management America where he served as Operations Manager and is responsible for the oversight of all middle and back office investment operations. ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for